id,input,output
0,"Inflammation is a biological response of the immune system that can be triggered by a variety of factors, including pathogens, damaged cells and toxic compounds. These factors may induce acute and/or chronic inflammatory responses in the heart, pancreas, liver, kidney, lung, brain, intestinal tract and reproductive system, potentially leading to tissue damage or disease.","[{'entity1': 'Inflammation', 'relationship': 'response', 'entity2': 'immune system'}, {'entity1': 'Inflammation', 'relationship': 'triggered by', 'entity2': 'factors'}, {'entity1': 'factors', 'relationship': 'induce', 'entity2': 'inflammatory responses'}, {'entity1': 'Inflammation', 'relationship': 'lead to', 'entity2': 'tissue damage'}, {'entity1': 'Inflammation', 'relationship': 'lead to', 'entity2': 'disease'}]"
1,"Both infectious and non-infectious agents and cell damage activate inflammatory cells and trigger inflammatory signaling pathways, most commonly the NF-κB, MAPK, and JAK-STAT pathways.","[{'entity1': 'agents', 'relationship': 'activate', 'entity2': 'inflammatory cells'}, {'entity1': 'agents', 'relationship': 'trigger', 'entity2': 'signaling pathways'}, {'entity1': 'agents', 'relationship': 'infectious', 'entity2': 'inflammatory cells'}, {'entity1': 'agents', 'relationship': 'non-infectious', 'entity2': 'inflammatory cells'}, {'entity1': 'cell damage', 'relationship': 'activate', 'entity2': 'inflammatory cells'}]"
2,"Inflammation is the immune system’s response to harmful stimuli, such as pathogens, damaged cells, toxic compounds, or irradiation, and acts by removing injurious stimuli and initiating the healing process.","[{'entity1': 'Inflammation', 'relationship': 'response to', 'entity2': 'stimuli'}, {'entity1': 'Inflammation', 'relationship': 'acts by', 'entity2': 'removing stimuli'}, {'entity1': 'Inflammation', 'relationship': 'acts by', 'entity2': 'initiating healing process'}]"
3,"Inflammation is therefore a defense mechanism that is vital to health. Usually, during acute inflammatory responses, cellular and molecular events and interactions efficiently minimize impending injury or infection.","[{'entity1': 'Inflammation', 'relationship': 'defense mechanism', 'entity2': 'health'}, {'entity1': 'Inflammation', 'relationship': 'minimize', 'entity2': 'injury'}, {'entity1': 'Inflammation', 'relationship': 'minimize', 'entity2': 'infection'}]"
4,"However, uncontrolled acute inflammation may become chronic, contributing to a variety of chronic inflammatory diseases.","[{'entity1': 'acute inflammation', 'relationship': 'become', 'entity2': 'chronic'}, {'entity1': 'acute inflammation', 'relationship': 'contribute to', 'entity2': 'inflammatory diseases'}]"
5,"At the tissue level, inflammation is characterized by redness, swelling, heat, pain, and loss of tissue function, which result from local immune, vascular and inflammatory cell responses to infection or injury.","[{'entity1': 'Inflammation', 'relationship': 'characterized by', 'entity2': 'redness'}, {'entity1': 'Inflammation', 'relationship': 'characterized by', 'entity2': 'swelling'}, {'entity1': 'Inflammation', 'relationship': 'characterized by', 'entity2': 'heat'}, {'entity1': 'Inflammation', 'relationship': 'characterized by', 'entity2': 'pain'}, {'entity1': 'Inflammation', 'relationship': 'result from', 'entity2': 'immune responses'}, {'entity1': 'Inflammation', 'relationship': 'result from', 'entity2': 'vascular responses'}, {'entity1': 'Inflammation', 'relationship': 'result from', 'entity2': 'inflammatory cell responses'}]"
6,"Important microcirculatory events that occur during the inflammatory process include vascular permeability changes, leukocyte recruitment and accumulation, and inflammatory mediator release.","[{'entity1': 'microcirculatory events', 'relationship': 'occur during', 'entity2': 'inflammatory process'}, {'entity1': 'events', 'relationship': 'include', 'entity2': 'permeability changes'}, {'entity1': 'events', 'relationship': 'include', 'entity2': 'leukocyte recruitment'}, {'entity1': 'events', 'relationship': 'include', 'entity2': 'inflammatory mediator release'}]"
7,"Various pathogenic factors, such as infection, tissue injury, or cardiac infarction, can induce inflammation by causing tissue damage.","[{'entity1': 'pathogenic factors', 'relationship': 'induce', 'entity2': 'inflammation'}, {'entity1': 'pathogenic factors', 'relationship': 'cause', 'entity2': 'tissue damage'}, {'entity1': 'infection', 'relationship': 'induce', 'entity2': 'inflammation'}, {'entity1': 'tissue injury', 'relationship': 'induce', 'entity2': 'inflammation'}, {'entity1': 'cardiac infarction', 'relationship': 'induce', 'entity2': 'inflammation'}]"
8,"The etiologies of inflammation can be infectious or non-infectious. In response to tissue injury, the body initiates a chemical signaling cascade that stimulates responses aimed at healing affected tissues.","[{'entity1': 'etiologies', 'relationship': 'infectious', 'entity2': 'inflammation'}, {'entity1': 'etiologies', 'relationship': 'non-infectious', 'entity2': 'inflammation'}, {'entity1': 'tissue injury', 'relationship': 'initiates', 'entity2': 'signaling cascade'}, {'entity1': 'signaling cascade', 'relationship': 'stimulates', 'entity2': 'responses'}, {'entity1': 'responses', 'relationship': 'aimed at', 'entity2': 'healing tissues'}]"
9,"The inflammatory response is the coordinate activation of signaling pathways in inflammatory mediator levels in resident tissue cells and inflammatory cells recruited from the blood. Inflammation is a common pathogenesis of many chronic diseases, including cardiovascular and bowel diseases, diabetes, arthritis, and cancer.","[{'entity1': 'Inflammatory response', 'relationship': 'activation', 'entity2': 'signaling pathways'}, {'entity1': 'Inflammatory response', 'relationship': 'pathogenesis', 'entity2': 'Chronic diseases'}, {'entity1': 'Inflammatory response', 'relationship': 'pathogenesis', 'entity2': 'Cardiovascular diseases'}, {'entity1': 'Inflammatory response', 'relationship': 'pathogenesis', 'entity2': 'Diabetes'}, {'entity1': 'Inflammatory response', 'relationship': 'pathogenesis', 'entity2': 'Arthritis'}, {'entity1': 'Inflammatory response', 'relationship': 'pathogenesis', 'entity2': 'Cancer'}]"
10,Pattern recognition receptor activation involves microbial structures known as pathogen-associated molecular patterns (PAMPs) triggering the inflammatory response through activation of germline-encoded pattern-recognition receptors (PRRs) expressed in both immune and nonimmune cells.,"[{'entity1': 'Pattern recognition receptor activation', 'relationship': 'involves', 'entity2': 'Microbial structures'}, {'entity1': 'Pattern recognition receptor activation', 'relationship': 'triggers', 'entity2': 'Inflammatory response'}, {'entity1': 'Pattern recognition receptor activation', 'relationship': 'activation', 'entity2': 'Pattern-recognition receptors'}, {'entity1': 'Pattern recognition receptor activation', 'relationship': 'expressed', 'entity2': 'Immune cells'}, {'entity1': 'Pattern recognition receptor activation', 'relationship': 'expressed', 'entity2': 'Nonimmune cells'}]"
11,"TLRs are a family of highly conserved, mammalian PRRs that participate in the activation of the inflammatory response. More than ten members of the TLR family have been identified, and TLRs are the most well-studied of the known PRRs.","[{'entity1': 'TLRs', 'relationship': 'participate', 'entity2': 'Inflammatory response'}, {'entity1': 'TLRs', 'relationship': 'identified', 'entity2': 'Members'}, {'entity1': 'TLRs', 'relationship': 'studied', 'entity2': 'PRRs'}]"
12,"Inflammatory pathways impact the pathogenesis of a number of chronic diseases, and involve common inflammatory mediators and regulatory pathways. Inflammatory stimuli activate intracellular signaling pathways that then activate production of inflammatory mediators. Primary inflammatory stimuli, including microbial products and cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), mediate inflammation through interaction with the TLRs, IL-1 receptor (IL-1R), IL-6 receptor (IL-6R), and the TNF receptor (TNFR). Receptor activation triggers important intracellular signaling pathways, including the mitogen-activated protein kinase (MAPK), nuclear factor kappa-B (NF-κB), and Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathways.","[{'entity1': 'Inflammatory pathways', 'relationship': 'impact', 'entity2': 'pathogenesis of chronic diseases'}, {'entity1': 'Inflammatory stimuli', 'relationship': 'activate', 'entity2': 'intracellular signaling pathways'}, {'entity1': 'Interleukin-1β', 'relationship': 'mediate', 'entity2': 'inflammation'}, {'entity1': 'Interleukin-6', 'relationship': 'mediate', 'entity2': 'inflammation'}, {'entity1': 'Tumor necrosis factor-α', 'relationship': 'mediate', 'entity2': 'inflammation'}, {'entity1': 'Interleukin-1R', 'relationship': 'interaction with', 'entity2': 'Inflammatory stimuli'}, {'entity1': 'IL-6R', 'relationship': 'interaction with', 'entity2': 'Inflammatory stimuli'}, {'entity1': 'TNFR', 'relationship': 'interaction with', 'entity2': 'Inflammatory stimuli'}, {'entity1': 'Receptor activation', 'relationship': 'triggers', 'entity2': 'intracellular signaling pathways'}, {'entity1': 'NF-κB', 'relationship': 'important roles in', 'entity2': 'inflammatory response'}, {'entity1': 'NF-κB', 'relationship': 'important roles in', 'entity2': 'immune response'}, {'entity1': 'NF-κB', 'relationship': 'important roles in', 'entity2': 'survival processes'}, {'entity1': 'NF-κB', 'relationship': 'important roles in', 'entity2': 'apoptosis processes'}, {'entity1': 'NF-κB', 'relationship': 'activity induced by', 'entity2': 'stimuli'}, {'entity1': 'IκB proteins', 'relationship': 'inhibit', 'entity2': 'NF-κB'}, {'entity1': 'PRRs', 'relationship': 'activate', 'entity2': 'IκB kinase'}, {'entity1': 'IKK', 'relationship': 'regulates', 'entity2': 'NF-κB pathway activation'}, {'entity1': 'IκB phosphorylation', 'relationship': 'results in', 'entity2': 'degradation by proteasome'}, {'entity1': 'NF-κB', 'relationship': 'release for', 'entity2': 'nuclear translocation'}, {'entity1': 'NF-κB', 'relationship': 'release for', 'entity2': 'gene transcription activation'}, {'entity1': 'NF-κB pathway', 'relationship': 'regulates', 'entity2': 'pro-inflammatory cytokine production'}, {'entity1': 'NF-κB pathway', 'relationship': 'regulates', 'entity2': 'inflammatory cell recruitment'}, {'entity1': 'MAPK', 'relationship': 'comprises', 'entity2': 'MAPK kinase'}, {'entity1': 'MAPK', 'relationship': 'comprises', 'entity2': 'MAPK kinase kinase'}, {'entity1': 'ERK1/2', 'relationship': 'activated by', 'entity2': 'mitogens'}, {'entity1': 'ERK1/2', 'relationship': 'activated by', 'entity2': 'differentiation signals'}, {'entity1': 'JNK', 'relationship': 'activated by', 'entity2': 'inflammatory stimuli'}, {'entity1': 'JNK', 'relationship': 'activated by', 'entity2': 'stress'}, {'entity1': 'MKK1', 'relationship': 'activate', 'entity2': 'ERK1/2'}, {'entity1': 'MKK2', 'relationship': 'activate', 'entity2': 'ERK1/2'}, {'entity1': 'MKK4', 'relationship': 'activate', 'entity2': 'JNK'}, {'entity1': 'MKK7', 'relationship': 'activate', 'entity2': 'JNK'}, {'entity1': 'MKK3', 'relationship': 'activate', 'entity2': 'p38'}, {'entity1': 'MKK6', 'relationship': 'activate', 'entity2': 'p38'}]"
13,"The NF-κB transcription factor plays important roles in inflammatory, immune response, survival, and apoptosis processes. The NF-κB family includes five related transcription factors: P50, p52, RelA (p65), RelB, and c-Rel. NF-κB activity is induced by a range of stimuli, including pathogen-derived substances, intercellular inflammatory cytokines, and many enzymes. Under physiological conditions, IκB proteins present in the cytoplasm inhibit NF-κB. PRRs use similar signal transduction mechanisms to activate IκB kinase (IKK), which is composed of two kinase subunits, IKKα and IKKβ, and a regulatory subunit, such as IKKγ. IKK regulates NF-κB pathway activation through IκB phosphorylation. IκB phosphorylation results in its degradation by the proteasome and the subsequent release of NF-κB for nuclear translocation and gene transcription activation. This pathway regulates pro-inflammatory cytokine production and inflammatory cell recruitment, which contribute to the inflammatory response.","[{'entity1': 'NF-κB', 'relationship': 'plays roles in', 'entity2': 'inflammatory processes'}, {'entity1': 'NF-κB', 'relationship': 'plays roles in', 'entity2': 'immune response'}, {'entity1': 'NF-κB', 'relationship': 'plays roles in', 'entity2': 'survival processes'}, {'entity1': 'NF-κB', 'relationship': 'plays roles in', 'entity2': 'apoptosis processes'}, {'entity1': 'NF-κB', 'relationship': 'activity induced by', 'entity2': 'stimuli'}, {'entity1': 'IκB proteins', 'relationship': 'inhibit', 'entity2': 'NF-κB'}, {'entity1': 'PRRs', 'relationship': 'activate', 'entity2': 'IκB kinase'}, {'entity1': 'IKK', 'relationship': 'regulates', 'entity2': 'NF-κB pathway activation'}, {'entity1': 'IκB phosphorylation', 'relationship': 'results in', 'entity2': 'degradation by proteasome'}, {'entity1': 'NF-κB', 'relationship': 'release for', 'entity2': 'nuclear translocation'}, {'entity1': 'NF-κB', 'relationship': 'release for', 'entity2': 'gene transcription activation'}, {'entity1': 'NF-κB pathway', 'relationship': 'regulates', 'entity2': 'pro-inflammatory cytokine production'}, {'entity1': 'NF-κB pathway', 'relationship': 'regulates', 'entity2': 'inflammatory cell recruitment'}]"
14,"MAPKs are a family of serine/threonine protein kinases that direct cellular responses to a variety of stimuli, including osmotic stress, mitogens, heat shock, and inflammatory cytokines (such as IL-1, TNF-α, and IL-6), which regulate cell proliferation, differentiation, cell survival and apoptosis. The mammalian MAPKs include extracellular-signal-regulated kinase ERK1/2, p38 MAP Kinase, and c-Jun N-terminal kinases (JNK). Each MAPK signaling pathway comprises at least three components: a MAPK, a MAPK kinase (MAPKK), and a MAPK kinase kinase (MAPKKK). MAPKKKs phosphorylate and activate MAPKKs, which in turn phosphorylate and activate MAPKs. ERKs are generally activated by mitogens and differentiation signals, while inflammatory stimuli and stress activate JNK and p38. MKK1 and MKK2 activate ERK1/2, MKK4 and MKK7 activate JNK, and MKK3 and MKK6 activate p38.","[{'entity1': 'MAPKs', 'relationship': 'direct', 'entity2': 'cellular responses'}, {'entity1': 'MAPKs', 'relationship': 'regulate', 'entity2': 'cell proliferation'}, {'entity1': 'MAPKs', 'relationship': 'regulate', 'entity2': 'cell differentiation'}, {'entity1': 'MAPKs', 'relationship': 'regulate', 'entity2': 'cell survival'}, {'entity1': 'MAPKs', 'relationship': 'regulate', 'entity2': 'apoptosis'}, {'entity1': 'MAPKs', 'relationship': 'activated by', 'entity2': 'mitogens'}, {'entity1': 'MAPKs', 'relationship': 'activated by', 'entity2': 'differentiation signals'}, {'entity1': 'JNK', 'relationship': 'activated by', 'entity2': 'inflammatory stimuli'}, {'entity1': 'JNK', 'relationship': 'activated by', 'entity2': 'stress'}, {'entity1': 'MKK1', 'relationship': 'activate', 'entity2': 'ERK1/2'}, {'entity1': 'MKK2', 'relationship': 'activate', 'entity2': 'ERK1/2'}, {'entity1': 'MKK4', 'relationship': 'activate', 'entity2': 'JNK'}, {'entity1': 'MKK7', 'relationship': 'activate', 'entity2': 'JNK'}, {'entity1': 'MKK3', 'relationship': 'activate', 'entity2': 'p38'}, {'entity1': 'MKK6', 'relationship': 'activate', 'entity2': 'p38'}]"
15,"Activation of the MAPKs, including Erk1/2, JNK, leads to phosphorylation and activation of p38 transcription factors.","[{'entity1': 'MAPKs', 'relationship': 'activation', 'entity2': 'Erk1/2'}, {'entity1': 'MAPKs', 'relationship': 'activation', 'entity2': 'JNK'}, {'entity1': 'JNK', 'relationship': 'activation', 'entity2': 'p38 transcription factors'}]"
16,"Signaling through TLRs activates intracellular signaling cascades that lead to nuclear translocation of AP-1 and NF-κB or IRF3, which regulates the inflammatory response.","[{'entity1': 'TLRs', 'relationship': 'activates', 'entity2': 'intracellular signaling cascades'}, {'entity1': 'intracellular signaling cascades', 'relationship': 'lead to', 'entity2': 'nuclear translocation of AP-1'}, {'entity1': 'intracellular signaling cascades', 'relationship': 'lead to', 'entity2': 'NF-κB or IRF3'}]"
17,"NF-κB signaling requires IKK subunits, which regulate pathway activation through IκB phosphorylation.","[{'entity1': 'NF-κB signaling', 'relationship': 'requires', 'entity2': 'IKK subunits'}, {'entity1': 'IKK subunits', 'relationship': 'regulate', 'entity2': 'pathway activation'}, {'entity1': 'IKK subunits', 'relationship': 'regulate', 'entity2': 'IκB phosphorylation'}]"
18,Cytoplasmic STATs recruited to these sites undergo phosphorylation and subsequent dimerization before translocation to the nucleus.,"[{'entity1': 'Cytoplasmic STATs', 'relationship': 'undergo', 'entity2': 'phosphorylation'}, {'entity1': 'Cytoplasmic STATs', 'relationship': 'undergo', 'entity2': 'dimerization'}, {'entity1': 'Cytoplasmic STATs', 'relationship': 'translocation to', 'entity2': 'the nucleus'}]"
19,Binding of IL-6 family members to plasma membrane receptors activates the JAK-STAT proteins.,"[{'entity1': 'IL-6 family members', 'relationship': 'binding to', 'entity2': 'plasma membrane receptors'}, {'entity1': 'plasma membrane receptors', 'relationship': 'activates', 'entity2': 'JAK-STAT proteins'}]"
20,"Cytokines, such as IL-1β, IL-6, TNF-α, and inflammatory proteins and enzymes, serve as biomarkers for diseases diagnosis, prognosis, and therapeutic decision making. Inflammatory cytokines are released from immune cells and play a role in inflammation and immune response regulation.","[{'entity1': 'Cytokines', 'relationship': 'serve as', 'entity2': 'biomarkers'}, {'entity1': 'Cytokines', 'relationship': 'released from', 'entity2': 'immune cells'}, {'entity1': 'Cytokines', 'relationship': 'play a role in', 'entity2': 'inflammation'}, {'entity1': 'Cytokines', 'relationship': 'play a role in', 'entity2': 'immune response'}]"
21,"Inflammatory cytokines are classified as ILs, colony stimulating factors, IFNs, TNFs, TGFs, and chemokines. They are produced by cells to recruit leukocytes to the site of infection or injury. Excessive production of inflammatory cytokines can lead to tissue damage, organ failure, and death.","[{'entity1': 'Inflammatory cytokines', 'relationship': 'classified as', 'entity2': 'ILs'}, {'entity1': 'Inflammatory cytokines', 'relationship': 'produced by', 'entity2': 'cells'}, {'entity1': 'Inflammatory cytokines', 'relationship': 'recruit', 'entity2': 'leukocytes'}, {'entity1': 'Inflammatory cytokines', 'relationship': 'lead to', 'entity2': 'tissue damage'}]"
22,"Inflammatory proteins in the blood, including CRP, haptoglobin, serum amyloid A, fibrinogen, and alpha 1-acid glycoprotein, help restore homeostasis and reduce microbial growth independently of antibodies. Abnormal activation of enzymes like HMGB1, SOD, GPx, NOX, iNOS, and COX-2 play key roles in inflammation-related diseases.","[{'entity1': 'Inflammatory proteins', 'relationship': 'help restore', 'entity2': 'homeostasis'}, {'entity1': 'Inflammatory proteins', 'relationship': 'reduce', 'entity2': 'microbial growth'}, {'entity1': 'Enzymes', 'relationship': 'play key roles in', 'entity2': 'inflammation-related diseases'}]"
23,"Oxidative stress can induce production of reactive oxygen species, malondialdehyde, deoxyguanosine, and isoprostanes, which can activate various transcription factors and increase expression of genes encoding growth factors, inflammatory cytokines, and chemokines. Oxidative stress is associated with the pathogenesis of cardiovascular disease, cancer, diabetes, hypertension, aging, and atherosclerosis.","[{'entity1': 'Oxidative stress', 'relationship': 'induce production of', 'entity2': 'reactive oxygen species'}, {'entity1': 'Oxidative stress', 'relationship': 'associated with', 'entity2': 'pathogenesis of diseases'}, {'entity1': 'Oxidative stress products', 'relationship': 'used as markers of', 'entity2': 'inflammatory response'}]"
24,The inflammatory response involves a network of many cell types. Different cell types are activated during the inflammatory response.,"[{'entity1': 'Inflammatory response', 'relationship': 'involves', 'entity2': 'network of cell types'}, {'entity1': 'Cell types', 'relationship': 'activated during', 'entity2': 'inflammatory response'}]"
25,Oxidative stress products can also be used as markers of the inflammatory response.,"[{'entity1': 'Oxidative stress products', 'relationship': 'markers', 'entity2': 'inflammatory response'}]"
26,The inflammatory response involves a highly coordinated network of many cell types.,"[{'entity1': 'inflammatory response', 'relationship': 'involves', 'entity2': 'cell types'}]"
27,Monocytes can differentiate into macrophages and dendritic cells and are recruited via chemotaxis into damaged tissues.,"[{'entity1': 'Monocytes', 'relationship': 'differentiate into', 'entity2': 'macrophages'}, {'entity1': 'Monocytes', 'relationship': 'differentiate into', 'entity2': 'dendritic cells'}, {'entity1': 'Monocytes', 'relationship': 'recruited via', 'entity2': 'chemotaxis'}]"
28,"Neutrophils, which target microorganisms in the body, can also damage host cells and tissues.","[{'entity1': 'Neutrophils', 'relationship': 'target', 'entity2': 'microorganisms'}, {'entity1': 'Neutrophils', 'relationship': 'damage', 'entity2': 'host cells'}, {'entity1': 'Neutrophils', 'relationship': 'damage', 'entity2': 'tissues'}]"
29,"Macrophages are important components of the mononuclear phagocyte system, and are critical in inflammation initiation, maintenance, and resolution.","[{'entity1': 'Macrophages', 'relationship': 'components of', 'entity2': 'mononuclear phagocyte system'}, {'entity1': 'Macrophages', 'relationship': 'critical in', 'entity2': 'inflammation initiation'}, {'entity1': 'Macrophages', 'relationship': 'critical in', 'entity2': 'inflammation maintenance'}, {'entity1': 'Macrophages', 'relationship': 'critical in', 'entity2': 'inflammation resolution'}]"
30,"Macrophages are critical in inflammation initiation, maintenance, and resolution. During inflammation, macrophages present antigens, undergo phagocytosis, and modulate the immune response by producing cytokines and growth factors.","[{'entity1': 'Macrophages', 'relationship': 'critical', 'entity2': 'inflammation'}, {'entity1': 'Macrophages', 'relationship': 'present', 'entity2': 'antigens'}, {'entity1': 'Macrophages', 'relationship': 'modulate', 'entity2': 'immune response'}]"
31,"Mast cells are effector cells that initiate inflammatory responses. Activated mast cells release a variety of inflammatory mediators, including cytokines, chemokines, histamine, proteases, prostaglandins, leukotrienes, and serglycin proteoglycans.","[{'entity1': 'Mast cells', 'relationship': 'initiate', 'entity2': 'inflammatory responses'}, {'entity1': 'Mast cells', 'relationship': 'release', 'entity2': 'inflammatory mediators'}]"
32,"Platelets impact inflammatory processes, from atherosclerosis to infection. Platelet interactions with inflammatory cells may mediate pro-inflammatory outcomes. Some studies have indicated that platelets induce the acute phase response (APR).","[{'entity1': 'Platelets', 'relationship': 'impact', 'entity2': 'inflammatory processes'}, {'entity1': 'Platelets', 'relationship': 'interactions', 'entity2': 'inflammatory cells'}, {'entity1': 'Platelets', 'relationship': 'induce', 'entity2': 'acute phase response'}]"
33,"Inflammation resolution is a well-managed process involving the spatially- and temporally-controlled production of mediators, during which chemokine gradients are diluted over time. Dysregulation of this process can lead to uncontrolled chronic inflammation.","[{'entity1': 'Inflammation resolution', 'relationship': 'process', 'entity2': 'mediators'}, {'entity1': 'Inflammation resolution', 'relationship': 'lead to', 'entity2': 'chronic inflammation'}]"
34,"Chronic inflammation occurs when acute inflammatory mechanisms fail to eliminate tissue injury, and may lead to diseases such as cardiovascular diseases, atherosclerosis, type 2 diabetes, rheumatoid arthritis, and cancers.","[{'entity1': 'Chronic inflammation', 'relationship': 'occurs when', 'entity2': 'acute inflammatory mechanisms'}, {'entity1': 'Chronic inflammation', 'relationship': 'lead to', 'entity2': 'cardiovascular diseases'}, {'entity1': 'Chronic inflammation', 'relationship': 'lead to', 'entity2': 'type 2 diabetes'}]"
35,"Inflammation has long been recognized as a major cause of disease. Acute and chronic inflammation-mediated tissue injury is observed in many organ systems, including the heart, pancreas, liver, kidney, lung, brain, intestinal tract, and reproductive system.","[{'entity1': 'Inflammation', 'relationship': 'recognized as', 'entity2': 'cause of disease'}, {'entity1': 'Inflammation', 'relationship': 'observed in', 'entity2': 'organ systems'}]"
36,"Inflammatory mediators play key roles in atherosclerosis, from initial leukocyte recruitment through rupture of the atherosclerotic plaque. Inflammation is also an early event in cardiac stress.","[{'entity1': 'Inflammatory mediators', 'relationship': 'play', 'entity2': 'atherosclerosis'}, {'entity1': 'Inflammation', 'relationship': 'event', 'entity2': 'cardiac stress'}]"
37,Elevated levels of endothelial adhesion molecules and increased inflammatory cytokine and chemokine production and release are observed in affected cardiac tissues.,"[{'entity1': 'Endothelial adhesion molecules', 'relationship': 'levels', 'entity2': 'cardiac tissues'}, {'entity1': 'Inflammatory cytokine', 'relationship': 'production', 'entity2': 'cardiac tissues'}]"
38,Myocardial infarction commonly results from coronary atherosclerosis and involves acute loss of many myocardial cells. Necrotic cardiac cells initiate an inflammatory cascade to clear dead cells and debris from the infarct.,"[{'entity1': 'Myocardial infarction', 'relationship': 'results', 'entity2': 'coronary atherosclerosis'}, {'entity1': 'Necrotic cardiac cells', 'relationship': 'initiate', 'entity2': 'inflammatory cascade'}]"
39,"Cardiovascular disease is the main cause of death and disability in patients with diabetes mellitus, especially those with type 2 diabetes (T2D), in whom cardiovascular disease occurs 14.6 years earlier on average.","[{'entity1': 'Cardiovascular disease', 'relationship': 'cause', 'entity2': 'death and disability'}, {'entity1': 'Type 2 diabetes', 'relationship': 'associated with', 'entity2': 'cardiovascular disease'}]"
40,"Diabetes complications include heart attack, stroke, kidney failure, limb amputation, blindness, and nerve damage. Diabetes results from either impaired insulin production in the pancreas or body cells not responding to produced insulin.","[{'entity1': 'Diabetes complications', 'relationship': 'include', 'entity2': 'heart attack'}, {'entity1': 'Diabetes', 'relationship': 'results from', 'entity2': 'impaired insulin production'}]"
41,"Diabetes results from either impaired insulin production in the pancreas or body cells not responding to produced insulin. Insulin resistance is defined as decreased insulin-stimulated glucose uptake, and is associated with inactivity, obesity, and aging.","[{'entity1': 'Diabetes', 'relationship': 'results from', 'entity2': 'impaired insulin production'}, {'entity1': 'Insulin resistance', 'relationship': 'defined as', 'entity2': 'decreased insulin-stimulated glucose uptake'}, {'entity1': 'Insulin resistance', 'relationship': 'associated with', 'entity2': 'inactivity'}, {'entity1': 'Insulin resistance', 'relationship': 'associated with', 'entity2': 'obesity'}, {'entity1': 'Insulin resistance', 'relationship': 'associated with', 'entity2': 'aging'}]"
42,"Elevated circulating levels of acute-phase proteins, including CRP, fibrinogen, serum amyloid A, plasminogen activator inhibitor, and haptoglobin, along with sialic acid, cytokines, and chemokines, have been observed in patients with T2D.","[{'entity1': 'Elevated levels', 'relationship': 'observed in', 'entity2': 'patients with T2D'}, {'entity1': 'CRP', 'relationship': 'part of', 'entity2': 'acute-phase proteins'}, {'entity1': 'Fibrinogen', 'relationship': 'part of', 'entity2': 'acute-phase proteins'}, {'entity1': 'Serum amyloid A', 'relationship': 'part of', 'entity2': 'acute-phase proteins'}, {'entity1': 'Plasminogen activator inhibitor', 'relationship': 'part of', 'entity2': 'acute-phase proteins'}, {'entity1': 'Haptoglobin', 'relationship': 'part of', 'entity2': 'acute-phase proteins'}, {'entity1': 'Cytokines', 'relationship': 'part of', 'entity2': 'observed levels'}, {'entity1': 'Chemokines', 'relationship': 'part of', 'entity2': 'observed levels'}]"
43,"Pancreatitis is an inflammatory disease of the pancreas. Acute pancreatitis (AP) incidence ranges from 4–45 per 100,000 patients per year and increases annually by approximately 1.3–4.0% in most developed countries.","[{'entity1': 'Pancreatitis', 'relationship': 'inflammatory disease of', 'entity2': 'pancreas'}, {'entity1': 'Acute pancreatitis', 'relationship': 'has incidence range', 'entity2': '4–45 per 100,000 patients per year'}, {'entity1': 'Acute pancreatitis', 'relationship': 'increases annually by', 'entity2': '1.3–4.0% in most developed countries'}]"
44,"Pancreatic cancer results from dysregulation of oncogenes and tumor suppressor genes, as well as growth factors and their receptors, including epidermal growth factors, vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and many cytokines, such as TGF-β, IL-1, IL-6, TNF-α, and IL-8, which modulate pathways involved in growth and differentiation.","[{'entity1': 'Pancreatic cancer', 'relationship': 'results from', 'entity2': 'dysregulation of oncogenes and tumor suppressor genes'}, {'entity1': 'Pancreatic cancer', 'relationship': 'results from', 'entity2': 'growth factors and their receptors'}, {'entity1': 'Pancreatic cancer', 'relationship': 'modulated by', 'entity2': 'cytokines'}, {'entity1': 'cytokines', 'relationship': 'modulate', 'entity2': 'pathways'}]"
45,"VEGF and IL-8 are important angiogenic factors in PC, and acidosis-promoted upregulation of these genes can be mediated through NF-κB and AP-1 transactivation and cooperation.","[{'entity1': 'VEGF', 'relationship': 'important in', 'entity2': 'Pancreatic cancer'}, {'entity1': 'IL-8', 'relationship': 'important in', 'entity2': 'Pancreatic cancer'}, {'entity1': 'acidosis', 'relationship': 'promoted upregulation of', 'entity2': 'VEGF and IL-8'}, {'entity1': 'acidosis', 'relationship': 'mediated through', 'entity2': 'NF-κB and AP-1'}]"
46,"Inflammation in the liver protects this organ from infection and injury, but excessive inflammation may lead to extensive loss of hepatocytes, ischemia-reperfusion injury, metabolic alterations, and eventually permanent hepatic damage.","[{'entity1': 'Inflammation', 'relationship': 'protects', 'entity2': 'liver'}, {'entity1': 'Inflammation', 'relationship': 'may lead to', 'entity2': 'loss of hepatocytes'}, {'entity1': 'Inflammation', 'relationship': 'may lead to', 'entity2': 'metabolic alterations'}, {'entity1': 'Inflammation', 'relationship': 'may lead to', 'entity2': 'permanent hepatic damage'}]"
47,Chronic liver diseases are a leading cause of morbidity and mortality in the US.,"[{'entity1': 'Chronic liver diseases', 'relationship': 'leading cause of', 'entity2': 'morbidity and mortality in the US'}]"
48,"Sterile inflammation (SI) is also important in the pathology of many liver diseases, such as alcoholic or nonalcoholic steatohepatitis, drug-induced liver injury, and ischemia/reperfusion.","[{'entity1': 'Sterile inflammation', 'relationship': 'important in', 'entity2': 'pathology of liver diseases'}, {'entity1': 'Sterile inflammation', 'relationship': 'associated with', 'entity2': 'alcoholic steatohepatitis'}, {'entity1': 'Sterile inflammation', 'relationship': 'associated with', 'entity2': 'drug-induced liver injury'}, {'entity1': 'Sterile inflammation', 'relationship': 'associated with', 'entity2': 'ischemia/reperfusion'}]"
49,"Lung inflammatory diseases involve complex interactions among and between structural and immune cells. Lung inflammation results predominantly from tissue exposure to bacterial and viral pathogens, and/or environmental pollutants. Excessive acute inflammation and subsequent lung injury can cause pulmonary fibrosis and impair gas exchange. Unresolved lung injury and chronic inflammation are frequently observed in acute respiratory distress syndrome, cystic fibrosis, chronic obstructive pulmonary disease (COPD), and asthma. Approximately 90% of COPD cases are associated with cigarette smoking-induced inflammation in small airways and lung parenchyma. Cigarette smoking is a major risk factor for COPD, which involves both systemic and pulmonary inflammation. Long-term smoking can cause macrophage, neutrophil, and activated T lymphocyte infiltration into airways, and promote production of chemokines, oxygen radicals, proteases, and cytokines, including that of TNF-α, IL-6 and IL-8, in the lung.","[{'entity1': 'Lung inflammatory diseases', 'relationship': 'involve', 'entity2': 'interactions'}, {'entity1': 'Lung inflammation', 'relationship': 'results from', 'entity2': 'tissue exposure'}, {'entity1': 'Lung injury', 'relationship': 'cause', 'entity2': 'pulmonary fibrosis'}, {'entity1': 'Lung injury', 'relationship': 'cause', 'entity2': 'impairment of gas exchange'}, {'entity1': 'COPD cases', 'relationship': 'associated with', 'entity2': 'cigarette smoking-induced inflammation'}, {'entity1': 'Cigarette smoking', 'relationship': 'risk factor for', 'entity2': 'COPD'}, {'entity1': 'Long-term smoking', 'relationship': 'cause', 'entity2': 'infiltration into airways'}, {'entity1': 'Long-term smoking', 'relationship': 'promote production of', 'entity2': 'chemokines'}, {'entity1': 'Long-term smoking', 'relationship': 'promote production of', 'entity2': 'cytokines'}]"
50,"Kidney inflammation contributes to progressive renal injury, which may lead to glomerulonephritis, end-stage renal disease, or acute or chronic kidney disease (CKD). Approximately 10–12% of the population suffers from CKD, and some 50% of elderly patients show signs of kidney dysfunction, which is associated with high morbidity and mortality. Kidney inflammation is most commonly induced by infection, ischemia/reperfusion, in situ immune-complex formation/deposition, or complement pathway dysregulation. CKD and acute kidney injury (AKI) are the most severe types of kidney disease. Interstitial inflammation and tubular injury are commonly observed in acute and chronic kidney injury cases. Renal tubular epithelial cells are likely important promoters of kidney inflammation, secreting a variety of inflammatory cytokines in response to both immune and non-immune factors, and leukocyte infiltration depends on the local presence of these cytokines. Stimuli that can induce kidney injury activate transcription factors (NF-κB or MAPK). These stimuli include cytokines, growth factors, DAMPs, and PAMPs, TLRs, Nod-like receptors (NLRs), and metabolic (high glucose, advanced glycosylation end products) and immune mediators.","[{'entity1': 'Kidney inflammation', 'relationship': 'contributes to', 'entity2': 'progressive renal injury'}, {'entity1': 'Progressive renal injury', 'relationship': 'may lead to', 'entity2': 'glomerulonephritis'}, {'entity1': 'Progressive renal injury', 'relationship': 'may lead to', 'entity2': 'end-stage renal disease'}, {'entity1': 'Progressive renal injury', 'relationship': 'may lead to', 'entity2': 'acute or chronic kidney disease'}, {'entity1': 'CKD cases', 'relationship': 'associated with', 'entity2': 'high morbidity and mortality'}, {'entity1': 'Kidney inflammation', 'relationship': 'induced by', 'entity2': 'infection'}, {'entity1': 'Kidney inflammation', 'relationship': 'induced by', 'entity2': 'ischemia/reperfusion'}, {'entity1': 'Kidney inflammation', 'relationship': 'induced by', 'entity2': 'immune-complex formation/deposition'}, {'entity1': 'Kidney inflammation', 'relationship': 'induced by', 'entity2': 'complement pathway dysregulation'}, {'entity1': 'AKI', 'relationship': 'type of', 'entity2': 'kidney disease'}, {'entity1': 'Renal tubular epithelial cells', 'relationship': 'promoters of', 'entity2': 'kidney inflammation'}, {'entity1': 'Renal tubular epithelial cells', 'relationship': 'secreting', 'entity2': 'inflammatory cytokines'}, {'entity1': 'Leukocyte infiltration', 'relationship': 'depends on', 'entity2': 'presence of cytokines'}, {'entity1': 'Stimuli', 'relationship': 'induce', 'entity2': 'kidney injury'}, {'entity1': 'Stimuli', 'relationship': 'include', 'entity2': 'cytokines'}, {'entity1': 'Stimuli', 'relationship': 'include', 'entity2': 'DAMPs'}, {'entity1': 'Stimuli', 'relationship': 'include', 'entity2': 'PAMPs'}, {'entity1': 'Stimuli', 'relationship': 'include', 'entity2': 'TLRs'}, {'entity1': 'Stimuli', 'relationship': 'include', 'entity2': 'NLRs'}, {'entity1': 'Stimuli', 'relationship': 'include', 'entity2': 'metabolic and immune mediators'}]"
51,"Intestinal tract acute and chronic inflammatory diseases of the intestine can cause various health issues, and decrease patient quality of life worldwide. The complex, polygenetic inflammatory bowel diseases (IBDs) are characterized by an excessive inflammatory response to gut lumen microbial flora. IBDs mainly include ulcerative colitis (UC) and Crohn disease (CD), but also noninfectious inflammation of the bowel.","[{'entity1': 'Intestinal tract', 'relationship': 'cause', 'entity2': 'health issues'}, {'entity1': 'Intestinal tract', 'relationship': 'decrease', 'entity2': 'patient quality of life'}, {'entity1': 'Inflammatory bowel diseases', 'relationship': 'characterized by', 'entity2': 'inflammatory response'}, {'entity1': 'Inflammatory bowel diseases', 'relationship': 'include', 'entity2': 'ulcerative colitis'}, {'entity1': 'Inflammatory bowel diseases', 'relationship': 'include', 'entity2': 'Crohn disease'}, {'entity1': 'Inflammatory bowel diseases', 'relationship': 'include', 'entity2': 'noninfectious inflammation'}]"
52,"Polygenetic inflammatory bowel diseases (IBDs) are characterized by an excessive inflammatory response to gut lumen microbial flora. IBDs mainly include ulcerative colitis (UC) and Crohn disease (CD), but also noninfectious inflammation of the bowel. Idiopathic IBDs, such as CD and UC, are caused by cytokine-driven, non-infectious inflammation of the gut. For example, CD is associated with excessive IFN-γ/IL-17 and IL-12/IL-23 production, while UC is associated with excess IL-13. Thus, IBD appears to be the result of a dysfunctional interaction between gut bacteria and the mucosal immune system. A key process in the immune system’s response to microbes is the recognition of microbial agents via PRRs, including TLRs and nucleotide-binding oligomerization domain containing NLRs, which sense evolutionarily conserved PAMPs. Upon PAMP detection, PRRs activate intracellular signaling pathways that induce production of cytokines and chemokines to promote host resistance to infection. TLR (mainly TLR4) signaling induces NF-κB and MAPK transcription. At the same time, NLRs are also activated through ligand detection, in turn activating caspase-1, followed by activation and secretion of IL-1β, interleukin-18 and other cytokines.","[{'entity1': 'Polygenetic inflammatory bowel diseases', 'relationship': 'characterized by', 'entity2': 'excessive inflammatory response'}, {'entity1': 'IBDs', 'relationship': 'include', 'entity2': 'ulcerative colitis'}, {'entity1': 'IBDs', 'relationship': 'include', 'entity2': 'Crohn disease'}, {'entity1': 'CD', 'relationship': 'associated with', 'entity2': 'excessive IFN-γ/IL-17 production'}, {'entity1': 'UC', 'relationship': 'associated with', 'entity2': 'excess IL-13'}, {'entity1': 'IBD', 'relationship': 'result of', 'entity2': 'dysfunctional interaction between gut bacteria and mucosal immune system'}, {'entity1': 'PRRs', 'relationship': 'sense', 'entity2': 'evolutionarily conserved PAMPs'}, {'entity1': 'PRRs', 'relationship': 'activate', 'entity2': 'intracellular signaling pathways'}, {'entity1': 'TLR4', 'relationship': 'induces', 'entity2': 'NF-κB transcription'}, {'entity1': 'NLRs', 'relationship': 'activated through', 'entity2': 'ligand detection'}, {'entity1': 'NLRs', 'relationship': 'activate', 'entity2': 'caspase-1'}, {'entity1': 'caspase-1', 'relationship': 'followed by', 'entity2': 'activation and secretion of IL-1β'}]"
53,"Reproductive system ovulation, and parturition trigger the inflammatory cascade. However, initiation and maintenance of inflammatory processes are also important components of many reproductive tract diseases. Damaged tissues locally release inflammatory interleukins, growth factors, cytokines, and prostaglandins, which activate signaling pathways and recruit immune cells (e.g. neutrophils and macrophages) to the site of injury. This process synergistically controls tissue remodeling and repair, but can also induce inflammatory diseases. Inflammatory cytokines, including IL-6, are the primary mediators of inflammation-related reproductive tract diseases, and act via signal transduction pathways such as the MAPK pathway.","[{'entity1': 'Reproductive system', 'relationship': 'trigger', 'entity2': 'inflammatory cascade'}, {'entity1': 'Damaged tissues', 'relationship': 'release', 'entity2': 'inflammatory interleukins'}, {'entity1': 'Damaged tissues', 'relationship': 'release', 'entity2': 'growth factors'}, {'entity1': 'Damaged tissues', 'relationship': 'release', 'entity2': 'cytokines'}, {'entity1': 'Damaged tissues', 'relationship': 'release', 'entity2': 'prostaglandins'}, {'entity1': 'Inflammatory cytokines', 'relationship': 'mediate', 'entity2': 'inflammation-related reproductive tract diseases'}, {'entity1': 'Inflammatory cytokines', 'relationship': 'act via', 'entity2': 'MAPK pathway'}]"
54,"Inflammatory responses occur in the brain in many central nervous system (CNS) diseases, including autoimmune diseases, neurodegenerative diseases like Alzheimer’s (AD) and Parkinson’s disease (PD), and epilepsy. Inflammatory responses in the brain can enhance neuronal excitability, injure cells, and increase blood-brain barrier permeability to various molecules. Inflammation-associated CNS diseases result from activation of the brain’s resident immune cells and microglia, which produce pro-inflammatory markers. These inflammation processes also involve both the innate and adaptive immune systems and resemble immune responses to systemic infection. Cytokines and TLRs are major inflammatory mediators in the transition between innate and adaptive. Inflammatory responses in the CNS may also be triggered by endogenous ligands recognized by TLRs. DAMPs, such as heat-shock proteins and extracellular matrix degradation molecules, entering the brain through a damaged blood-brain barrier may initiate inflammatory responses. The CNS inflammatory response is strong in reaction to both infectious agents and brain injury.","[{'entity1': 'Inflammatory responses', 'relationship': 'occur in', 'entity2': 'brain'}, {'entity1': 'Brain', 'relationship': 'enhance', 'entity2': 'neuronal excitability'}, {'entity1': 'Brain', 'relationship': 'injure', 'entity2': 'cells'}, {'entity1': 'Brain', 'relationship': 'increase', 'entity2': 'blood-brain barrier permeability'}, {'entity1': 'CNS diseases', 'relationship': 'result from', 'entity2': 'activation of brain’s resident immune cells and microglia'}, {'entity1': 'Inflammation processes', 'relationship': 'involve', 'entity2': 'innate and adaptive immune systems'}, {'entity1': 'Cytokines', 'relationship': 'mediate', 'entity2': 'inflammatory responses'}, {'entity1': 'TLRs', 'relationship': 'recognize', 'entity2': 'endogenous ligands'}, {'entity1': 'DAMPs', 'relationship': 'enter', 'entity2': 'brain through damaged blood-brain barrier'}, {'entity1': 'CNS inflammatory response', 'relationship': 'strong in reaction to', 'entity2': 'infectious agents'}]"
55,"Inflammation is frequently a key element in the pathological progression of organ disease. Three main pathways, NF-κB, MAPK, and JAK-STAT, play major roles in inflammation, and dysregulation of one or more of these pathways may lead to inflammation-associated disease.","[{'entity1': 'Inflammation', 'relationship': 'key element', 'entity2': 'pathological progression'}, {'entity1': 'NF-κB', 'relationship': 'role', 'entity2': 'inflammation'}, {'entity1': 'MAPK', 'relationship': 'role', 'entity2': 'inflammation'}, {'entity1': 'JAK-STAT', 'relationship': 'role', 'entity2': 'inflammation'}]"
56,"The hallmarks of inflammation are observed during many normal reproductive processes, including menstruation, ovulation, implantation, and parturition.","[{'entity1': 'Inflammation', 'relationship': 'hallmarks', 'entity2': 'reproductive processes'}, {'entity1': 'Menstruation', 'relationship': 'part of', 'entity2': 'normal reproductive processes'}, {'entity1': 'Ovulation', 'relationship': 'part of', 'entity2': 'normal reproductive processes'}, {'entity1': 'Implantation', 'relationship': 'part of', 'entity2': 'normal reproductive processes'}, {'entity1': 'Parturition', 'relationship': 'part of', 'entity2': 'normal reproductive processes'}]"
57,Inflammatory mechanisms: the molecular basis of inflammation and disease.,"[{'entity1': 'Inflammatory mechanisms', 'relationship': 'basis', 'entity2': 'Inflammation'}, {'entity1': 'Inflammatory mechanisms', 'relationship': 'basis', 'entity2': 'Disease'}]"
58,Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease.,"[{'entity1': 'Immune pathways', 'relationship': 'therapy', 'entity2': 'Asthma'}, {'entity1': 'Immune pathways', 'relationship': 'therapy', 'entity2': 'Chronic obstructive pulmonary disease'}]"
59,p53 and the Carcinogenicity of Chronic Inflammation.,"[{'entity1': 'p53', 'relationship': 'Carcinogenicity', 'entity2': 'Chronic Inflammation'}]"
60,Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.,"[{'entity1': 'Hydrophobicity', 'relationship': 'initiates', 'entity2': 'Innate immune responses'}]"
61,The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.,"[{'entity1': 'Pattern recognition', 'relationship': 'defined by', 'entity2': 'Cooperation'}, {'entity1': 'Pattern recognition', 'relationship': 'of pathogens', 'entity2': 'Innate immune system'}]"
62,"Altered ROS production, NF-κB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells.","[{'entity1': 'ROS production', 'relationship': 'altered by', 'entity2': 'electrical stimulation'}, {'entity1': 'NF-κB activation', 'relationship': 'induced by', 'entity2': 'electrical stimulation'}, {'entity1': 'Interleukin-6 gene expression', 'relationship': 'induced by', 'entity2': 'electrical stimulation'}, {'entity1': 'dystrophic mdx skeletal muscle cells', 'relationship': 'affected by', 'entity2': 'electrical stimulation'}]"
63,Role of perinatal inflammation in cerebral palsy.,"[{'entity1': 'perinatal inflammation', 'relationship': 'role in', 'entity2': 'cerebral palsy'}]"
64,Inflammatory cytokines in the pathogenesis of periventricular leukomalacia.,"[{'entity1': 'Inflammatory cytokines', 'relationship': 'involved in', 'entity2': 'pathogenesis'}, {'entity1': 'Inflammatory cytokines', 'relationship': 'associated with', 'entity2': 'periventricular leukomalacia'}]"
65,The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?,"[{'entity1': 'JAK/STAT pathway', 'relationship': 'associated with', 'entity2': 'rheumatoid arthritis'}, {'entity1': 'JAK/STAT pathway', 'relationship': 'role', 'entity2': 'pathogenic'}, {'entity1': 'JAK/STAT pathway', 'relationship': 'role', 'entity2': 'protective'}]"
66,The myocardial JAK/STAT pathway: from protection to failure.,"[{'entity1': 'myocardial JAK/STAT pathway', 'relationship': 'transition', 'entity2': 'protection'}, {'entity1': 'myocardial JAK/STAT pathway', 'relationship': 'transition', 'entity2': 'failure'}]"
67,Inflammatory markers and onset of cardiovascular events.,"[{'entity1': 'Inflammatory markers', 'relationship': 'associated with', 'entity2': 'onset of cardiovascular events'}]"
68,Inflammatory markers and the risk of coronary heart disease in men and women.,"[{'entity1': 'Inflammatory markers', 'relationship': 'risk of', 'entity2': 'coronary heart disease'}, {'entity1': 'Inflammatory markers', 'relationship': 'risk of', 'entity2': 'men'}, {'entity1': 'Inflammatory markers', 'relationship': 'risk of', 'entity2': 'women'}]"
69,"Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.","[{'entity1': 'Inflammatory markers', 'relationship': 'association with', 'entity2': 'essential hypertension'}, {'entity1': 'C-reactive protein', 'relationship': 'association with', 'entity2': 'essential hypertension'}, {'entity1': 'Interleukin-6', 'relationship': 'association with', 'entity2': 'essential hypertension'}, {'entity1': 'TNF-alpha', 'relationship': 'association with', 'entity2': 'essential hypertension'}]"
70,Cytokine Dysregulation in Chronic Kidney Disease: How Can We Treat It?,"[{'entity1': 'Cytokine Dysregulation', 'relationship': 'in', 'entity2': 'Chronic Kidney Disease'}, {'entity1': 'Cytokine Dysregulation', 'relationship': 'treatment', 'entity2': 'Chronic Kidney Disease'}]"
71,Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway.,"[{'entity1': 'Dexmedetomidine', 'relationship': 'attenuates', 'entity2': 'inflammatory reaction'}, {'entity1': 'Dexmedetomidine', 'relationship': 'activating', 'entity2': 'cholinergic anti-inflammatory pathway'}, {'entity1': 'septic mice', 'relationship': 'lung tissues', 'entity2': 'inflammatory reaction'}]"
72,"HMGB1, a potent proinflammatory cytokine in sepsis.","[{'entity1': 'HMGB1', 'relationship': 'potent', 'entity2': 'proinflammatory cytokine'}, {'entity1': 'HMGB1', 'relationship': 'sepsis', 'entity2': 'cytokine'}]"
73,"Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK, NF-κB pathways.","[{'entity1': 'Mitochondrial ROS', 'relationship': 'govern', 'entity2': 'pro-inflammatory response'}, {'entity1': 'Mitochondrial ROS', 'relationship': 'regulating', 'entity2': 'MAPK, NF-κB pathways'}, {'entity1': 'microglia cells', 'relationship': 'LPS-induced', 'entity2': 'pro-inflammatory response'}]"
74,"Oxidative stress, inflammation, and cancer: how are they linked?","[{'entity1': 'Oxidative stress', 'relationship': 'linked', 'entity2': 'Inflammation'}, {'entity1': 'Inflammation', 'relationship': 'linked', 'entity2': 'Cancer'}]"
75,Inflammation and Cardiovascular Disease and Protection by the Mediterranean Diet.,"[{'entity1': 'Inflammation', 'relationship': 'associated with', 'entity2': 'Cardiovascular Disease'}, {'entity1': 'Mediterranean Diet', 'relationship': 'protection', 'entity2': 'Cardiovascular Disease'}]"
76,Cocoa Polyphenols and Inflammatory Markers of Cardiovascular Disease.,"[{'entity1': 'Cocoa Polyphenols', 'relationship': 'impact on', 'entity2': 'Inflammatory Markers'}, {'entity1': 'Cocoa Polyphenols', 'relationship': 'associated with', 'entity2': 'Cardiovascular Disease'}]"
77,Mechanisms governing resolution of lung inflammation.,"[{'entity1': 'Mechanisms', 'relationship': 'governing', 'entity2': 'Resolution'}, {'entity1': 'Resolution', 'relationship': 'of', 'entity2': 'Lung inflammation'}]"
78,Neutrophils and immunity: challenges and opportunities.,"[{'entity1': 'Neutrophils', 'relationship': 'and', 'entity2': 'Immunity'}, {'entity1': 'Challenges', 'relationship': 'of', 'entity2': 'Neutrophils'}, {'entity1': 'Opportunities', 'relationship': 'of', 'entity2': 'Neutrophils'}]"
79,Macrophages in inflammation.,"[{'entity1': 'Macrophages', 'relationship': 'in', 'entity2': 'Inflammation'}]"
80,Regulation and function of mast cell proteases in inflammation.,"[{'entity1': 'Regulation', 'relationship': 'of', 'entity2': 'Mast cell proteases'}, {'entity1': 'Mast cell proteases', 'relationship': 'in', 'entity2': 'Inflammation'}]"
81,Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.,"[{'entity1': 'Inflammation', 'relationship': 'in', 'entity2': 'Pathogenesis'}, {'entity1': 'Inflammation', 'relationship': 'in', 'entity2': 'Heart failure'}, {'entity1': 'Therapeutic target', 'relationship': 'as', 'entity2': 'Inflammation'}]"
82,"Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.","[{'entity1': 'Interleukin-6 signaling', 'relationship': 'in', 'entity2': 'Heart failure'}, {'entity1': 'Soluble glycoprotein 130', 'relationship': 'and', 'entity2': 'Inflammation'}]"
83,The immune system and cardiac repair.,"[{'entity1': 'Immune system', 'relationship': 'and', 'entity2': 'Cardiac repair'}]"
84,Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses.,"[{'entity1': 'Endogenous ligands', 'relationship': 'of', 'entity2': 'Toll-like receptors'}, {'entity1': 'Regulating', 'relationship': 'for', 'entity2': 'Implications'}, {'entity1': 'Inflammatory responses', 'relationship': 'and', 'entity2': 'Immune responses'}]"
85,Toll-like receptors in cardiovascular disease.,"[{'entity1': 'Toll-like receptors', 'relationship': 'in', 'entity2': 'Cardiovascular disease'}]"
86,"Oxygen, oxidative stress, hypoxia, and heart failure.","[{'entity1': 'Oxygen', 'relationship': 'and', 'entity2': 'Oxidative stress'}, {'entity1': 'Oxidative stress', 'relationship': 'and', 'entity2': 'Hypoxia'}, {'entity1': 'Hypoxia', 'relationship': 'and', 'entity2': 'Heart failure'}]"
87,Oxidative stress and cardiovascular injury are part of the basic mechanisms in heart failure. Monitoring of ROS is essential in vivo.,"[{'entity1': 'Oxidative stress', 'relationship': 'part of', 'entity2': 'Cardiovascular injury'}, {'entity1': 'Monitoring', 'relationship': 'essential in', 'entity2': 'ROS'}]"
88,Regulating the NF-κB signaling in the heart is crucial. NF-κB plays a role in heart regulation.,"[{'entity1': 'NF-κB', 'relationship': 'regulating', 'entity2': 'heart'}, {'entity1': 'NF-κB', 'relationship': 'plays a role in', 'entity2': 'heart regulation'}]"
89,Chemokines are associated with various diseases. They control lymphocyte traffic.,"[{'entity1': 'Chemokines', 'relationship': 'associated with', 'entity2': 'diseases'}, {'entity1': 'Chemokines', 'relationship': 'control', 'entity2': 'lymphocyte traffic'}]"
90,TNFα and IL-10 imbalance in heart failure is studied. Understanding the biology of TNFα and IL-10 is important.,"[{'entity1': 'TNFα', 'relationship': 'imbalance in', 'entity2': 'heart failure'}, {'entity1': 'IL-10', 'relationship': 'imbalance in', 'entity2': 'heart failure'}, {'entity1': 'TNFα', 'relationship': 'biology of', 'entity2': 'heart failure'}, {'entity1': 'IL-10', 'relationship': 'biology of', 'entity2': 'heart failure'}]"
91,Role of IL-1β in type 2 diabetes.,"[{'entity1': 'IL-1β', 'relationship': 'role', 'entity2': 'Type 2 diabetes'}]"
92,Type 2 diabetes as an inflammatory disease.,"[{'entity1': 'Type 2 diabetes', 'relationship': 'inflammatory disease', 'entity2': 'None'}]"
93,Pathogenic mechanisms of pancreatitis.,"[{'entity1': 'Pathogenic mechanisms', 'relationship': 'of', 'entity2': 'Pancreatitis'}]"
94,The epidemiology of pancreatitis and pancreatic cancer.,"[{'entity1': 'Epidemiology', 'relationship': 'of', 'entity2': 'Pancreatitis'}, {'entity1': 'Epidemiology', 'relationship': 'of', 'entity2': 'Pancreatic cancer'}]"
95,Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.,"[{'entity1': 'Immune cells', 'relationship': 'role', 'entity2': 'Pancreatitis'}, {'entity1': 'Immune-based therapies', 'relationship': 'role', 'entity2': 'Pancreatitis'}, {'entity1': 'Immune cells', 'relationship': 'role', 'entity2': 'Pancreatic ductal adenocarcinoma'}, {'entity1': 'Immune-based therapies', 'relationship': 'role', 'entity2': 'Pancreatic ductal adenocarcinoma'}]"
96,"Physiology and pathophysiology of liver inflammation, damage and repair.","[{'entity1': 'liver inflammation', 'relationship': 'damage', 'entity2': 'repair'}]"
97,Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage.,"[{'entity1': 'Cytokines', 'relationship': 'induced', 'entity2': 'chronic hepatitis B virus infection'}, {'entity1': 'Cytokines', 'relationship': 'promote', 'entity2': 'pathway'}, {'entity1': 'NK cell', 'relationship': 'mediated', 'entity2': 'liver damage'}]"
98,Innate immunity in alcoholic liver disease.,"[{'entity1': 'Innate immunity', 'relationship': 'associated with', 'entity2': 'alcoholic liver disease'}]"
99,Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease.,"[{'entity1': 'immune pathways', 'relationship': 'targeting', 'entity2': 'therapy'}, {'entity1': 'asthma', 'relationship': 'therapy', 'entity2': 'immune pathways'}, {'entity1': 'chronic obstructive pulmonary disease', 'relationship': 'therapy', 'entity2': 'immune pathways'}]"
100,Lung inflammation caused by inhaled toxicants: a review.,"[{'entity1': 'Lung inflammation', 'relationship': 'caused by', 'entity2': 'inhaled toxicants'}]"
101,"Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls.","[{'entity1': 'blood inflammatory cells', 'relationship': 'responsiveness', 'entity2': 'Japanese COPD patients'}, {'entity1': 'sputum inflammatory cells', 'relationship': 'responsiveness', 'entity2': 'Japanese COPD patients'}, {'entity1': 'blood inflammatory cells', 'relationship': 'responsiveness', 'entity2': 'non-COPD smoking controls'}, {'entity1': 'sputum inflammatory cells', 'relationship': 'responsiveness', 'entity2': 'non-COPD smoking controls'}, {'entity1': 'blood inflammatory cells', 'relationship': 'responsiveness', 'entity2': 'non-COPD nonsmoking controls'}, {'entity1': 'sputum inflammatory cells', 'relationship': 'responsiveness', 'entity2': 'non-COPD nonsmoking controls'}]"
102,NFκBiz protein downregulation in acute kidney injury: Modulation of inflammation and survival in tubular cells.,"[{'entity1': 'NFκBiz protein', 'relationship': 'downregulation in', 'entity2': 'acute kidney injury'}, {'entity1': 'NFκBiz protein', 'relationship': 'modulation of', 'entity2': 'inflammation'}, {'entity1': 'NFκBiz protein', 'relationship': 'modulation of', 'entity2': 'survival'}, {'entity1': 'NFκBiz protein', 'relationship': 'modulation of', 'entity2': 'tubular cells'}]"
103,NF-kappaB in renal inflammation.,"[{'entity1': 'NF-kappaB', 'relationship': 'in', 'entity2': 'renal inflammation'}]"
104,"Inflammation plays a crucial role in the development of cancer, especially in gynecological malignancies. The interplay between inflammation and cancer is a significant area of research in oncology.","[{'entity1': 'Inflammation', 'relationship': 'role', 'entity2': 'Cancer'}, {'entity1': 'Inflammation', 'relationship': 'development', 'entity2': 'Gynecological malignancies'}]"
105,Microglia in diseases of the central nervous system have been studied extensively. The role of microglia in neurotoxicity and neurodegeneration is a key focus in neuroscience research.,"[{'entity1': 'Microglia', 'relationship': 'role', 'entity2': 'Central nervous system'}, {'entity1': 'Microglia', 'relationship': 'focus', 'entity2': 'Neurotoxicity'}, {'entity1': 'Microglia', 'relationship': 'focus', 'entity2': 'Neurodegeneration'}]"
